Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
02/2003
02/11/2003CA2071375C Heterocyclic derivatives
02/11/2003CA2068871C Non-glycosylated fgf-4 and compositions containing the same
02/10/2003WO2002014320A2 Novel substituted diaryl azepine derivatives as integrin ligands
02/10/2003CA2419078A1 Substituted diaryl azepine derivatives as integrin ligands
02/10/2003CA2394781A1 Skin care composition that changes color upon drying
02/06/2003WO2003010310A1 Method of examining allergic disease
02/06/2003WO2003010298A1 'probiotic lactobacillus salivarius strains
02/06/2003WO2003010297A1 Probiotic bifidobacterium strains
02/06/2003WO2003010290A2 Novel class ii cytokine receptors and uses thereof
02/06/2003WO2003010286A2 Nucleic acids, polypeptides, and methods for modulating apoptosis
02/06/2003WO2003010173A1 Stabilized derivatives of ascorbic acid -3-phosphate
02/06/2003WO2003010135A1 Novel phenylpropionic acid derivatives
02/06/2003WO2003009898A1 Treatment of hair follicle with neurokinin 1 receptor antagonists
02/06/2003WO2003009877A1 Topical pharmaceutical formulation
02/06/2003WO2003009867A1 Use of biologically active hiv-1 tat, fragments or derivates thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases
02/06/2003WO2003009866A1 Use of the disintegrin domain of an adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent
02/06/2003WO2003009860A1 Preparation used for the topical treatment of pains and skin diseases
02/06/2003WO2003009849A1 Process for the preparation of 2-(2-(4-(bis(4-fluorophenyl)methyl)-piperazin-1-yl)ethoxy)acetic acid derivatives or corresponding salt forms thereof and intermediates therefor
02/06/2003WO2003009847A1 Substituted piperidines as modulators of the melanocortin receptor
02/06/2003WO2003009842A1 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same
02/06/2003WO2003009841A1 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
02/06/2003WO2003009830A1 Coated granules of allylamine- or benzylamine-anti-mycotics
02/06/2003WO2003009828A1 Modifying the fatty acid composition of cell membranes of organs and tissues
02/06/2003WO2003009820A2 Methods for promotion of hair growth comprising topical application of prostaglandin analogues
02/06/2003WO2003009813A2 Methods of treating neuropilin-mediated diseases
02/06/2003WO2003009810A2 Silver alginate foam compositions
02/06/2003WO2003009807A2 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
02/06/2003WO2003009802A2 Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide
02/06/2003WO2003009800A1 Sustained-release therapeutic bioadhesive systems
02/06/2003WO2003009689A1 Methods and compositions for treating fungal infections
02/06/2003WO2002097068A3 Keratinocytes obtained from embryonic stem cells of mammals
02/06/2003WO2002095034A3 A retinoic acid metabolizing cytochrome p450
02/06/2003WO2002093177A3 Assays for identifying modulators of rhomboid polypeptides
02/06/2003WO2002079146A3 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
02/06/2003WO2002064586A3 Heterocyclic inhibitors of erk2 and uses thereof
02/06/2003WO2002061110A3 Nucleic acid derivatives
02/06/2003WO2002059112A3 Pyrazole compounds useful as protein kinase inhibitors
02/06/2003WO2002041843A3 Antiinflammation agents
02/06/2003WO2002028904A3 Human anti-cd40 antibodies
02/06/2003WO2002019963A3 Synthetic erythropoiesis stimulating proteins
02/06/2003WO2002014470A3 Expression of herstatin, an alternative her-2/neu product, in cells that express either p185her-2 or the egf receptor inhibits receptor activity and cell growth
02/06/2003WO2002010217A9 Endothelial cell expression patterns
02/06/2003WO2002010137A9 Indazole derivatives as jnk inhibitors
02/06/2003WO2002002645A8 COLD WATER SOLUBLE β-GLUCAN PRODUCT AND PROCESS FOR PREPARING THE SAME
02/06/2003WO2002002095A3 Compositions for treating bacterial infections containing oxazolidinone compound, sulbactam and an ampicillin
02/06/2003WO2001088199A3 Identification and modulationof of a t helper-1 and t helper-2 cells
02/06/2003US20030028008 Nucleotide sequences coding polypeptide for use in the treatment of urogenital, tumor, antherosclerotic and kidney disorders
02/06/2003US20030027999 143 human secreted proteins
02/06/2003US20030027864 Compositions comprising a compound of low solubility and a lipophilic amino acid derivative, uses thereofand process for dissolving a compound of low solubility
02/06/2003US20030027851 Readily soluble crystal modification; specific X-ray diffraction pattern obtained with a focusing Debye-Scherrer beam and Cu-K alpha 1-radiation
02/06/2003US20030027845 Ether derivatives useful as inhibitors of PDE4 isozymes
02/06/2003US20030027830 Administering to a cancer patient an effective amount of chalcone or its derivaties to treat the tumor/cancer
02/06/2003US20030027820 Method for treating fibrotic diseases or other indications V
02/06/2003US20030027800 LPA receptor agonists and antagonists and methods of use
02/06/2003US20030027794 N-heterocyclic derivatives as NOS inhibitors
02/06/2003US20030027772 Composition containing at least one inhibitor of the enzyme 3-beta-HSD
02/06/2003US20030027337 Sequence-specific DNA recombination in eukaryotic cells
02/06/2003US20030027299 Biochemical conjugate for use in the treatment or prevention of stroke, heart defect, veinous thrombosis, sepsis and embolism
02/06/2003US20030027261 Novel genes TZap7/A, TZap7/B and TZap7 involved in T cell activation and uses thereof
02/06/2003US20030027211 Fetuin-MGP-mineral complex in serum
02/06/2003US20030027158 Novel nucleic acid sequences encoding human breast tumor-associated protein 47-like polypeptides
02/06/2003US20030026820 Use of a compositon containing an effective quantity of at least one ion chelating agent for increasing the tolerance threshold of a sensitive or intolerant skin
02/06/2003US20030026819 Protective coating for skin
02/06/2003US20030026776 Water-soluble ginger root extract
02/06/2003US20030026774 Mixture of quaternary ammonium compound and polyalcohol
02/06/2003CA2857312A1 Nucleic acids, polypeptides, and methods for modulating apoptosis using deoxyhypusine synthase (dhs)
02/06/2003CA2462600A1 Silver alginate foam compositions
02/06/2003CA2454822A1 Nucleic acids, polypeptides, and methods for modulating apoptosis using apoptosis-specific eif-5a
02/06/2003CA2454803A1 Probiotic bifidobacterium strains
02/06/2003CA2454802A1 Novel class ii cytokine receptors and uses thereof
02/06/2003CA2454656A1 Methods and compositions for treating fungal infections
02/06/2003CA2454564A1 Process for the preparation of 2-(2-(4-(bis(4-fluorophenyl)methyl)-piperazin-1-yl)ethoxy)acetic acid derivatives or corresponding salt forms thereof and intermediates therefor
02/06/2003CA2454150A1 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same
02/06/2003CA2453561A1 Use of the disintegrin domain of an adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent
02/06/2003CA2452328A1 Substituted piperidines as modulators of the melanocortin receptor
02/06/2003CA2452159A1 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
02/06/2003CA2449462A1 Methods for promotion of hair growth comprising topical application of prostaglandin analogues
02/05/2003WO2002014280A1 Piperidine derivatives and drugs containing these derivatives as the active ingredient
02/05/2003EP1281763A2 Early growth response-1 (EGR-1) transcription factor
02/05/2003EP1281402A1 Water-soluble ginger root extract
02/05/2003EP1281401A2 The medical effect of Jojoba oil
02/05/2003EP1281399A2 Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production
02/05/2003EP1281398A1 Dermal compositions containing coenzyme q as the active ingredient
02/05/2003EP1281396A2 Skin vitalizing composition for external use anti-aging preparation
02/05/2003EP1281394A2 Processes for cosmetics
02/05/2003EP1281392A1 Cosmetic or/and pharmaceutical compositions containing plant extracts
02/05/2003EP1280908A2 Treatment of neoplasia / transformation using pituitary tumor transforming gene 2
02/05/2003EP1280907A2 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods
02/05/2003EP1280906A2 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg)
02/05/2003EP1280888A1 Cell culture method, cell cluster obtained by said methods and use thereof
02/05/2003EP1280826A2 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci
02/05/2003EP1280820A2 Anti-inflammatory compounds and uses thereof
02/05/2003EP1280815A1 29 human secreted proteins
02/05/2003EP1280806A1 THIENO 2,3-d]PYRIMIDINEDIONES AND THEIR USE AS PHARMACEUTICALS
02/05/2003EP1280799A1 Ortho-substituted anthranilic acid amides and their use as medicaments
02/05/2003EP1280798A1 Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them
02/05/2003EP1280777A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
02/05/2003EP1280776A1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
02/05/2003EP1280766A1 Biocidal polymers based on guanidine salts
02/05/2003EP1280757A2 New gamma selective retinoids
1 ... 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 ... 1065